Below are the most recent publications written about "Receptors, Dopamine D4" by people in Profiles.
-
Yang JJ, Wang Z, Trucco EM, Buu A, Lin HC. Chronic pain and delinquency partially explain the effect of the DRD4 gene polymorphism on adult substance use. Am J Drug Alcohol Abuse. 2022 03 04; 48(2):235-244.
-
Vancura P, Abdelhadi S, Csicsely E, Baba K, Tosini G, Iuvone PM, Spessert R. Gnaz couples the circadian and dopaminergic system to G protein-mediated signaling in mouse photoreceptors. PLoS One. 2017; 12(10):e0187411.
-
Vancura P, Wolloscheck T, Baba K, Tosini G, Iuvone PM, Spessert R. Circadian and Dopaminergic Regulation of Fatty Acid Oxidation Pathway Genes in Retina and Photoreceptor Cells. PLoS One. 2016; 11(10):e0164665.
-
Trucco EM, Hicks BM, Villafuerte S, Nigg JT, Burmeister M, Zucker RA. Temperament and externalizing behavior as mediators of genetic risk on adolescent substance use. J Abnorm Psychol. 2016 05; 125(4):565-75.
-
Villalba K, Devieux JG, Rosenberg R, Cadet JL. DRD2 and DRD4 genes related to cognitive deficits in HIV-infected adults who abuse alcohol. Behav Brain Funct. 2015 Aug 27; 11:25.
-
Sampson D, Zhu XY, Eyunni SV, Etukala JR, Ofori E, Bricker B, Lamango NS, Setola V, Roth BL, Ablordeppey SY. Identification of a new selective dopamine D4 receptor ligand. Bioorg Med Chem. 2014 Jun 15; 22(12):3105-14.
-
Sasaki JY, Kim HS, Mojaverian T, Kelley LD, Park IY, Janusonis S. Religion priming differentially increases prosocial behavior among variants of the dopamine D4 receptor (DRD4) gene. Soc Cogn Affect Neurosci. 2013 Feb; 8(2):209-15.
-
Pozdeyev N, Tosini G, Li L, Ali F, Rozov S, Lee RH, Iuvone PM. Dopamine modulates diurnal and circadian rhythms of protein phosphorylation in photoreceptor cells of mouse retina. Eur J Neurosci. 2008 May; 27(10):2691-700.
-
Lyles-Eggleston M, Altundas R, Xia J, Sikazwe DM, Fan P, Yang Q, Li S, Zhang W, Zhu X, Schmidt AW, Vanase-Frawley M, Shrihkande A, Villalobos A, Borne RF, Ablordeppey SY. Design, synthesis, and evaluation of metabolism-based analogues of haloperidol incapable of forming MPP+-like species. J Med Chem. 2004 Jan 29; 47(3):497-508.
-
Merchant KM, Gill GS, Harris DW, Huff RM, Eaton MJ, Lookingland K, Lutzke BS, Mccall RB, Piercey MF, Schreur PJ, Sethy VH, Smith MW, Svensson KA, Tang AH, Vonvoigtlander PF, Tenbrink RE. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist. J Pharmacol Exp Ther. 1996 Dec; 279(3):1392-403.